Long-Term Cardiovascular Effects of Medications for Attention-Deficit/Hyperactivity Disorder—Balancing Benefits and Risks of Treatment-Reference-Cited by-同舟云学术

Long-Term Cardiovascular Effects of Medications for Attention-Deficit/Hyperactivity Disorder—Balancing Benefits and Risks of Treatment

Published:2023-11-22 Issue: Volume: Page:
ISSN:2168-622X
Container-title:JAMA Psychiatry
language:en
Short-container-title:JAMA Psychiatry

Author:

Cortese Samuele¹²³⁴,Fava Cristiano⁵⁶

Affiliation:

1. Centre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, United Kingdom

2. Solent NHS Trust, Southampton, United Kingdom

3. School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom

4. Hassenfeld Children’s Hospital at NYU Langone, New York University Child Study Center, New York City

5. Department of Medicine, General Medicine & Hypertension Unit, University of Verona, Verona, Italy

6. Department of Clinical Sciences, Clinical Research Center, Lund University, Malmö, Sweden

Publisher

American Medical Association (AMA)

Subject

Psychiatry and Mental health

Link

https://jamanetwork.com/journals/jamapsychiatry/articlepdf/2811813/jamapsychiatry_cortese_2023_ed_230011_1699290240.76309.pdf

Reference10 articles.

1. Pharmacologic treatment of attention deficit-hyperactivity disorder.;Cortese;N Engl J Med,2020

2. Cardiovascular effects of stimulant and non-stimulant medication for children and adolescents with ADHD: a systematic review and meta-analysis of trials of methylphenidate, amphetamines, and atomoxetine.;Hennissen;CNS Drugs,2017

3. Long-term methylphenidate exposure and 24-hours blood pressure and left ventricular mass in adolescents and young adults with attention deficit hyperactivity disorder.;Buitelaar;Eur Neuropsychopharmacol,2022

4. Risk of cardiovascular diseases associated with medications used in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.;Zhang;JAMA Netw Open,2022

5. Attention-deficit/hyperactivity disorder medications and long-term risk of cardiovascular diseases.;Zhang;JAMA Psychiatry

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risques du méthylphénidate au long cours;Annales Médico-psychologiques, revue psychiatrique;2024-09

2. Why is ADHD so difficult to diagnose in older adults?;Expert Review of Neurotherapeutics;2024-08-04

3. Treatments in the pipeline for attention-deficit/hyperactivity disorder (ADHD) in adults;Neuroscience & Biobehavioral Reviews;2024-08